Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ana Muñoz Montiel"'
Autor:
Ana Muñoz Montiel, Pedro Ruiz-Esteban, Adolfo Doménech Del Río, Pedro Valdivielso, Miguel Ángel Sánchez Chaparro, Casilda Olveira
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Chronic obstructive pulmonary disease (COPD) has a high prevalence and a major impact on health-related quality of life (HRQL). COPD exacerbations are an important cause of morbidity and mortality, affecting cardiovascular risk, and are asso
Externí odkaz:
https://doaj.org/article/25f1a311c6b7416a83de649c8ad90abc
Autor:
Adolfo Doménech Del Río, Miguel Ángel Sánchez Chaparro, Esperanza Salcedo Lobera, Pedro Ruiz-Esteban, Ana Muñoz Montiel, Jairo Luque Del Pino
Publikováno v:
Monitoring airway disease.
Autor:
José Rioja Villodres, Pedro Ruiz-Esteban, María Jesús Prunera Pardell, Ana Muñoz Montiel, Miguel Ángel Sánchez Chaparro, Pedro Valdivielso Felices, Natalia Garcia Casares, Adolfo Doménech Del Río, Esperanza Salcedo Lobera
Publikováno v:
Rehabilitation and chronic care.
Autor:
Natalia García-Casares, Ana Muñoz-Montiel, José Rioja, Pedro Valdivielso, María Jesús Prunera Pardell, Adolfo Domenech, Pedro Ruiz-Esteban, Casilda Olveira, Patricia Gutiérrez Castaño, Miguel Ángel Sánchez-Chaparro
Publikováno v:
Respiratory medicine. 141
It is not known whether COPD exacerbations contribute to an increased vascular risk already associated with the disease. For this reason, we prospectively evaluated 127 patients referred for a monographic COPD consultation. We classify as exacerbator
Autor:
María Jesús Prunera Pardell, Patricia Gutiérrez Castaño, Ana Muñoz Montiel, Casilda Olveira Fuster, Adolfo Doménech Del Río, Miguel Angel Sanchez Chaparro
Publikováno v:
Monitoring Airway Disease.
Autor:
José Luis de la Cruz Ríos, Natalia Garcia Casares, Miguel Angel Sanchez Chaparro, Patricia Gutiérrez Castaño, Pedro Valdivieso Felices, Ana Muñoz Montiel, Adolfo Doménech Del Río
Publikováno v:
5.2 Monitoring Airway Disease.
Several observational and case-control studies have confirmed that patients with COPD have a higher risk of cardiovascular disorders. To compare the differences between frequent exacerbator phenotype (two or more events in the previous year) and infr